Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Boudi1959on Jun 11, 2021 4:58pm
174 Views
Post# 33374356

RE:RE:RE:RE:RE:RE:Camel toe moe and Sona bag holders

RE:RE:RE:RE:RE:RE:Camel toe moe and Sona bag holders

Saliva-based testing has shown accuracy in detecting positive coronavirus infection 83 percent of the time, while nose-throat swab tests have shown 85 percent accuracy, according to a review of dataTrusted Source from 16 studies including 5,900 participants published in JAMA Internal Medicine. 

The study authors also report that saliva-based testing has shown 99 percent accuracy at identifying negative cases for COVID-19, with a far less invasive and discomforting process.

Furthermore, the researchers suggest that the ease of use and good diagnostic performance of the saliva-based test may make it an attractive alternative that could bolster test rates. 

 


<< Previous
Bullboard Posts
Next >>